FP7H2020
Sveuciliste u Rijeci, Medicinski Fakultet
- Country
- HRCroatia
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 6
- EU contribution (CORDIS)
- EUR 6,075,009
- Active
- 2009 to 2022
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| Virus RePro IELReprogramming of IELs at the intestinal epithelial barrier during virus infection | H2020 | 2022 | Coordinator | EUR 147,464 |
| GLIOVACCAugmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | H2020 | 2018 | Coordinator | EUR 149,968 |
| PIXELPort IoT for Environmental Leverage | H2020 | 2018 | Participant | EUR 301,500 |
| OLEUMAdvanced solutions for assuring the overall authenticity and quality of olive oil | H2020 | 2016 | Participant | EUR 0 |
| GLYCOVAXA training network for the rational design of the next generation of well-defined glycoconjugate vaccines | H2020 | 2015 | Participant | EUR 247,761 |
| DRIVE-ABDRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE | FP7 | 2014 | Participant | EUR 24,300 |
| HTP-GLYCOMETMethods for high-throughput glycoproteomic analysis | FP7 | 2013 | Participant | EUR 317,099 |
| STADVINNStrengthening adaptive immunity via innate immunity: enhancing the CD8 T cell response by using the NKG2D ligand expressed in a herpesvirus vector | FP7 | 2013 | Coordinator | EUR 1,754,897 |
| NLONight-of-the-Lab-Out | FP7 | 2013 | Participant | EUR 2,889 |
| NKG2D in T-cellsMemory Control; The role of NKG2D and the T-cell receptor in memory T cell biology | FP7 | 2011 | Coordinator | EUR 173,221 |
| TRANSMEDRIUpgrading the capacities for research in translational medicine at the Faculty of Medicine University of Rijeka | FP7 | 2010 | Coordinator | EUR 1,853,941 |
| CAPRI2010The Center for Antibody Production Rijeka: Upgrading the Central Research and Service Infrastructure for the South Eastern Region of Europe | FP7 | 2009 | Coordinator | EUR 619,770 |
| INFLA-CAREUnderstanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies | FP7 | 2009 | Participant | EUR 482,200 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.